Health · 23 views
STAT+: At AACR, a provocative use of CAR-T, Merck’s new thing and cancer’s geography problem
At AACR, a bold use of CAR-T raises hopes and provocative questions about its use in smoldering multiple myeloma.
Health 
Story intelligence
Coverage Single outlet Single-outlet story
Views 23 Community interest
Brief read Under 1 min brief 23 words
AI Summary
Researchers at the American Association for Cancer Research (AACR) conference presented a novel application of CAR-T cell therapy in treating smoldering multiple myeloma.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedCoverage Context
Part of AACR coverage 3 tracked stories
More from Health
Continue reading recent Health coverage
- A moment that changed me: I felt hugely self conscious about my skin - until I had a revelationContinue reading
- AACR's annual cancer progress report highlights promising advances for patientsContinue reading
- Brain MRI surveillance without prophylactic cranial irradiation improves cognitive outcomes in small cell lung cancerContinue reading
- New model tracks vocal fold fatigue as it develops, study showsContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow